OrbiMed Advisors LLC's Form 4 filing
NeuroPace Inc (NPCE) · filed Oct 4, 2023
- Accession no.
- 0000947871-23-000978
- Filed
- Oct 4, 2023, 5:36 PM ET
- Trade date
- Oct 2-3, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $75.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| OrbiMed Advisors LLCCIK 0001055951 | 10% Owner |
| OrbiMed Capital GP VI LLCCIK 0001682115 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2023 | Common Stock | SSaleDisposed | −7,614 | $9.08 | −$69,135.12 | 4,004,667 | Indirect | |
| Oct 3, 2023 | Common Stock | SSaleDisposed | −700 | $9.02 | −$6,314 | 4,003,967 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.